Advia Chemistry Enzymatic Creatinine_2
Enzymatic Method, Creatinine. 510(k) K070727, from Siemens Medical Solutions Diagnostics (Tarrytown, NY). Product code JFY, class 2.
As of Nov 19, 2026, K070727 is an FDA 510(k) held by Siemens Medical Solutions Diagnostics, substantially equivalent on Aug 3, 2007 after 141 days, with 5 recalls tied to it in FDA's recall database.
- Review time: 141 days
- Recalls: 5
- Cited as a predicate by: 2 devices
For in vitro diagnostic use in the quantitative determination of creatinine in human serum, plasma, and urine on the ADVIA Chemistry Systems. Such measurements are used in the diagnosis and treatment of renal diseases, and in monitoring renal dialysis.
- Randox CreatinineK973993 · Randox Laboratories, Ltd. · Mar 6, 1998
- Additional Assays for The Bayer Advia 1650 Chemistry SystemK991576 · Bayer Corp. · Jun 30, 1999
- Atellica CH Enzymatic Creatinine_3 (ECre3)K212223 · Siemens Healthcare Diagnostics, Inc. · Nov 24, 2021
- Atellica CH Creatinine_2 (Crea_2), Atellica CH Chemistry Calibrator (CHEM CAL)K161494 · Siemens Healthcare Diagnostics, Inc. · Nov 15, 2016
| May 4, 2020 | Z-2282-2020, Z-2283-2020The presence of N-acetyl-p-benzoquinone imine (NAPQI), a metabolite of acetaminophen, may cause interference in certain chemistry assays when testing patient samples. | Terminated |
| Dec 18, 2019 | Z-1230-2020, Z-1231-2020There is a potential for falsely depressed creatinine results for patients on phenindione therapy when using the enzymatic methodology. Interference has not been observed with the creatinine Jaffe methodology. | Terminated |
| Mar 17, 2016 | Z-1654-2016Siemens Healthcare Diagnostics has become aware of N-Acetylcysteine (NAC) and Metamizole (Dipyrone) interference with Trinder and Trinder-like reaction assays. Siemens has confirmed that falsely depressed results may… | Terminated |
- Qscheck UisacrK252619 · Qstag, Inc. · Feb 20, 2026
- Atellica CH Enzymatic Creatinine_3 (ECre3)K212223 · Siemens Healthcare Diagnostics, Inc. · Nov 24, 2021
- Yumizen C1200 Creatinine PAPK193649 · Horiba Abx SAS · May 10, 2021
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Mar 15, 2007
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1225
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files